Unknown PHASE3 INTERVENTIONAL NCT00110201

The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure

Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients

Sponsor: Ejaz, Abulate A, MD

Conditions Acute Renal Failure Cardiovascular Disease Death

Interventions Nesiritide

Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Mar 31, 2005 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00110201, this PHASE3 trial focuses on Acute Renal Failure and Cardiovascular Disease and remains ongoing. Sponsored by Ejaz, Abulate A, MD, it has been updated 5 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ejaz, Abulate A, MD

Data source: Ejaz, Abulate A, MD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States